Vivos Therapeutics Inc (VVOS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate
Revenues	25.60% 3.016	4.054	3.419
Cost Of Revenue	7.41% 1.507	1.403	0.10
Gross Profit	43.08% 1.509	2.651	1.937
Operating Expenses	18.31% 5.427	4.587	5.722
Benefits Costs and Expenses	14.97% 6.88	5.984	7.182
Costs And Expenses	14.97% 6.88	5.984	7.182
Depreciation and Amortization	22.07% 0.177	0.145	0.146
Operating Income/Loss	102.38% -3.918	-1.936	-3.785
Income/Loss From Continuing Operations Before Tax	100.21% -3.864	-1.93	-3.763
Income/Loss From Continuing Operations After Tax	100.21% -3.864	-1.93	-3.763
Net Income/Loss	100.21% -3.864	-1.93	-3.763
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Basic Average Shares	166.24% 8.5953	3.2284	2.3082
Diluted Average Shares	166.24% 8.5953	3.2284	2.3082
Basic Earnings Per Share	25.00% -0.45	-0.60	-1.63
Diluted Earnings Per Share	25.00% -0.45	-0.60	-1.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

PODD

$292.89

2.10%

STE

$260.68

0.57%

DXCM

$68.43

2.38%

PHG

$29.43

1.06%

GEHC

$88.16

2.80%

$84.58

0.29%